Invert (YC W22) — Data analytics software for biomanufacturing
We build software to manage, analyze, and optimize bioprocessing data. Our initial customers are bio-industrial companies, who produce various products in bioreactors.
Invert is a Y Combinator company in the Winter 2022 batch. Its directory entry describes it as: Data analytics software for biomanufacturing. The founders listed are Martin T. Permin (Founder), Holger Thorup (Founder) (Y Combinator directory entry, March 25, 2022).
Get an email when Invert changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
We build software to manage, analyze, and optimize bioprocessing data. Our initial customers are bio-industrial companies, who produce various products in bioreactors.
Invert lists 1 open role on its directory entry.
Checked away from the directory entry. What is below does not come from the company's Y Combinator page.
Invert — Infrastructure and Intelligence for Bioprocess
Infrastructure and intelligence for bioprocess — for development and manufacturing teams at biopharma, synthetic biology, and CDMOs.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Martin T. Permin
Founder
Hi, I'm Martin. I care about bio and data stuff. I also like to run really long distances on mountain trails.
Previously, I worked at Airbnb, and Hive (YC s14).
Holger Thorup
Founder
Prev. VP of Eng at ZeroNorth, CTO/Founder at Pelion, and a recovering consultant.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 34 companies held here in Healthcare › Industrial Bio.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Invert?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Invert: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Invert covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Invert: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
